Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aimmune's peanut allergy drug clears Phase II on the way to a pivotal test
Aimmune's peanut allergy drug clears Phase II on the way to a pivotal test
Aimmune's peanut allergy drug clears Phase II on the way to a pivotal test
Submitted by
admin
on March 8, 2016 - 10:12am
Source:
Fierce Biotech
News Tags:
Aimmune
peanut allergy
AR101
clinical trials
Headline:
Aimmune's peanut allergy drug clears Phase II on the way to a pivotal test
Do Not Allow Advertisers to Use My Personal information
